Replies to post #134200 on ORIONS Money Stocks

[Boochy]

Golden crosses...

6/28/2011	CHUX	NASDAQ 
 6/28/2011	THFF	NASDAQ 
 6/28/2011	AFB	NYSE 
 6/28/2011	AKO.A	NYSE 
 6/28/2011	ATT	NYSE 
 6/28/2011	BBK	NYSE 
 6/28/2011	BIE	NYSE 
 6/28/2011	EVG	NYSE 
 6/28/2011	EXC	NYSE 
 6/28/2011	MVT	NYSE 
 6/28/2011	NCO	NYSE 
 6/28/2011	NMP	NYSE 
 6/28/2011	NQI	NYSE 
 6/28/2011	PCK	NYSE 
 6/28/2011	NMZ	AMEX 
 6/28/2011	NWI	AMEX 
 6/28/2011	NXI	AMEX 
 

~Boochy

[AugustaFriends]

Inhibitex initiated with a Outperform at Wedbush; tgt $9: . Wedbush initiates INHX with a Outperform and price target of $9 based on the conviction that Inhibitex could attract a high profile partnership or be an acquisition candidate. Firm notes INHX is developing one of only two later-clinical stage HCV drug candidates in the sought-after class of nucleotides which is not owned by or partnered to big pharma.